SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony@Pacific who started this subject3/11/2002 6:19:35 PM
From: songw   of 122087
 
more dio info

Diomed, newly listed on the Amex, was formed thru the merger of a former nasd bulletin board company (DIMD) and a pink sheet stock trading for a couple pennies in January 2002..
ANDOVER, Mass., Feb 19, 2002 /PRNewswire-FirstCall via COMTEX/ -- Diomed, Inc. (DIMD.BB), a provider of clinical modalities used in minimal and micro-invasive medical procedures, has announced that it completed its merger transaction with Diomed Holdings, Inc., a Nevada corporation formerly known as Natexco Corporation (the "Company").
pinksheets.com

According to Yahoo- since listing Diomed stock has appreciated 600%-(see chart)
4-Week Change +601%
4-Week Change +564.9%
relative to S&P500

pinksheets.com

At the close today the company sported a market cap of nearly $100m.

"In connection with the Merger, the Company conducted a private placement offering of its securities. In the private placement, investors subscribed to purchase from the Company an aggregate of 5,000,000 shares of its common stock pursuant to Section 4(2) of the Securities Act of 1933, as amended, at a price per share of $2.00 for aggregate gross proceeds of $10,000,000. "
old.edgarpro.com

Since listing on the Amex, Diomed has been the subject of a series of email campaigns by promoters hired and paid for in Diomed stock-all at prices well under the current market price.

OTC Journal's series of emails since Feb. 22 urging subscribers to buy Diomed.

otcjournal.com

OTC Journal's compensation for coverage"Profile Coverage: February 22, 2002 to February 22, 2003
AMEX Symbol: DIO
Compensation: MarketByte LLC has been paid a fee of $100,000 in cash and 250,000 options convertible into free trading shares, exercisable at $3.50, by the Mohammed Patel, an individual, for publishing information on Diomed Corp for a period of one year." otcjournal.com

Various info on Natexco/diomed

chart-note 52 week range
0.00125 to 9.00 bigcharts.marketwatch.com

Natexco/diomed news list pinksheets.com

pinksheets.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext